CCRN logo

CROSS COUNTRY HEALTHCARE INC

CCRNNASDAQ
πŸ† #3087 by market capEarnings Nov 10 Β· PostUS Equity
$13.26β–² $0.01 (+0.11%)
Market closed Β· at close
πŸ””
Track CCRN
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 0.1%
7dβ–² 0.0%
14dβ–² 0.0%
30dβ–² 0.0%
ytdβ–² 63.3%
1yβ–Ό 6.8%
🏦Market Cap
$428M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-21.6%
Declining
πŸ“ŠGross Margin
19.8%
Thin
πŸ’΅FCF Margin
4.0%
Moderate
βš–οΈP/S Ratio
0.4x
Cheap
Otter Score
92
Very Good

Trading Snapshot

Day Range
$13.10 – $13.38
52-Week Range
$7.43 – $14.99
Volume
$4.62B
Avg Volume
$4.54B
Shares Outstanding
32.3M
Next Earnings
Nov 27, 2026

Fundamentals Snapshot

Annual Revenue
$1.05B
Last Q Revenue
$241M
P/E Ratio
-4.3
P/S Ratio
0.4x
EPS (TTM)
$-3.13
Dividend Yield
0.00%
Dilution (1yr)
+0.0%

Why Investors Own CCRN

  • βœ“High-growth profile β€” revenue up +56.1% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 41% gross margin and 28% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

CCRN logo

CROSS COUNTRY HEALTHCARE INC

CCRN
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$1.1Bβ–Ό βˆ’21.6% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
18.7%β–Ό βˆ’8.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$3Mβ–Ό βˆ’79.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$40Mβ–Ό βˆ’64.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
32.3Mβ–² +0.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$106Mβ–² +$29M YoY
StockOtter Β· stockotter.space

About CROSS COUNTRY HEALTHCARE INC

Cross Country Healthcare, Inc. is a U.S.-based provider specializing in talent management and consultative advisory services for healthcare organizations. The company operates through two main divisions: Nurse and Allied Staffing, and Physician Staffing. The Nurse and Allied Staffing segment offers a broad range of recruitment and personnel solutions under the Cross Country brand. This includes both temporary and direct-hire placements for travel nurses, local nurses, and various allied health professionals. It sources registered nurses, licensed practical nurses, certified nurse assistants, practitioners, and pharmacists for per diem or short-term engagements, as well as clinical and non-clinical specialists for longer contract durations. Additionally, this segment delivers comprehensive workforce solutions, including Managed Service Programs (MSP), Recruitment Process Outsourcing (RPO), and consulting, alongside retained and contingent search services for healthcare professionals. Its diverse clientele spans public and private hospitals (both acute and non-acute care), government facilities, national and local healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care centers, and physician practice groups. The Physician Staffing segment, operating as Cross Country Locums, focuses on supplying independent contractor physicians across numerous specialties, certified registered nurse anesthetists (CRNAs), nurse practitioners, and physician assistants. These professionals are deployed on temporary assignments to various healthcare environments, such as acute and non-acute care facilities, medical group practices, government establishments, and managed care organizations. Cross Country Healthcare, Inc. was established in 1986 and is headquartered in Boca Raton, Florida.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Very Good
92/100

Analyst Ratings

β“˜
Consensus
Hold
14 analysts
Strong Buy0
Buy0
Hold11
Sell1
Strong Sell2
Ratings as of Sep 2026

Latest News & Updates